Breaking News

 AI’ll fix it

August 10, 2025
avatar-torie-bosch
First Opinion editor

I think about 15% of the essays submitted to First Opinion these days boil down to: "AI'll fix it."

Unsurprisingly, most of these pieces are written by executives at companies selling health care AI. Inevitably, I pass on them.

I'm not against publishing a piece written by a CEO — I think that it's often valuable to hear their perspectives and get them on the record.

But I am against essays that spend 80% of their words spelling out a (very real!) problem, and just 10% on the "solutions" part, handwaving away potential problems. It's ultimately unsatisfying. (You didn't ask, but the other 10% of the standard version of this essay? Usually it's in the conclusion and repeats the thesis statement with some starry-eyed big-picture language.)

It's not just that "AI will fix it" essays end up seeming too self-promotional — they also just aren't terribly interesting, absent some surprising argument.

I'm far more compelled by pieces that make a sharp point about AI's limitations. For instance, First Opinion published a really thought-provoking essay by Hamid Tizhoosh on the "AI pseudo-revolution" in health care. "Despite grand predictions that AI would revolutionize medicine — perhaps even replace doctors — its impact has instead stalled, hanging in the balance of inaccuracy, bias, and overhyped potential," he writes. Tizhoosh has been working in AI in medicine for 30 years and is disappointed to see health systems racing to adopt systems before they are truly ready. I highly recommend its clear-eyed look at AI.

It's part of STAT+, so it's behind the paywall. I wish we didn't need a paywall, but good journalism costs money to produce. The good news is that until tomorrow, you can get 50% off a STAT+ annual subscription. Go here and use code AUGUST50.

Recommendation of the week: I'm running dry here! What books, movies, TV shows, and podcasts have you enjoyed lately?



Adobe

Former surgeon general: The CDC shooting must be a wakeup call

Public health professionals, from CDC scientists to local health officials, face harassment, threats, and now gunfire for doing their jobs.

By Jerome Adams


The psychological toll of living in the metaphorical medical waiting room

New treatments, new possibilities, and new technologies extend and improve life. But waiting remains part of the medical journey.

By Judith Eguzoikpe


Doctors sometimes fake CPR — and they should

Slow codes are not only ethical in some circumstances — they might be essential in today's conflict-ridden medical landscape.

By Jason Adam Wasserman and Parker Crutchfield


Chagas disease is spread by triatomine insects, also known as
Adobe

A 'tropical' disease is spreading in American wildlife

A researcher was startled to find that half of the Illinois raccoons she sampled tested positive for the parasite that causes Chagas disease.

By Esther Onuselogu


Amid the countless tragedies of Gaza, chronic disease remains

My cousin is displaced in Gaza. But his familial Mediterranean fever remains, exacerbated by the war.

By Asil Almanssi


Trump deserves the Nobel Peace Prize for Operation Warp Speed's global impact

NYU's Marc Siegel says in a First Opinion essay that one way to shift the debate on mRNA vaccines is to give Trump the Nobel Prize for Operation Warp Speed.

By Marc Siegel


Adobe

Trump's firing of the Bureau of Labor Statistics commissioner puts crucial health data at risk

Trump firing BLS chief imperils data vital to public health, signals a deeper shift toward authoritarian control over information: a First Opinion essay.

By Lee Kennedy-Shaffer


Steve Forbes: CMS must cover FDA-approved medical devices and treatments

Aligning CMS reimbursement with FDA approvals would reintroduce predictability and practicality into a system that has for too long been short on both.

By Steve Forbes


Cancer care is in crisis — but I've seen what hope can do

Amid devastating research cuts, oncologists need a hope that's laced with determination and innovation through action.

By Fumiko Chino


Adobe

STAT+ | I've spent 30 years trying to harness AI to fight cancer. I'm dismayed by the AI pseudo-revolution

Terrified of slipping in rankings, hospitals are rushing to adopt AI — often without fully grasping their limitations, ethical implications, or efficacy.

By Hamid Tizhoosh


Americans should have access to drugs approved overseas

Congress should enact reciprocal approval for drugs and medical devices cleared by comparable countries.

By Jeffrey Singer and Bautista Vivanco


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments